COVID-19 Antibody Treatment

The U.S. Food and Drug Administration has issued several Emergency Use Authorizations for the use of anti-SARS-CoV-2 monoclonal antibodies . With the Department of Health and Human Services’ 9th Amendment to the Public Readiness and Emergency Preparedness (PREP) Act, licensed pharmacists are now authorized to both order and administer monoclonal antibodies as COVID-19 therapeutics for patients with mild-to-moderate COVID-19 in adult and pediatric patients. This therapy has shown to keep patients from potential requirement of hospitalization due to COVID-19 by 87%.

While effective, THIS THERAPY IS NOT A SUBSTITUTE FOR THE COVID-19 VACCINE.